Published 14 days ago

Weight-loss drug linked to sleep apnea reduction: Research

Zepbound, a weight loss drug, may benefit people with obstructive sleep apnea, according to drugmaker Eli Lilly.
Adults with obesity and sleep apnea showed improvement in sleep apnea and weight loss when treated with Zepbound, as per company's study results.
In a year, those with moderate-to-severe sleep apnea had a significant reduction in events per hour with the medication compared to a placebo group.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Reuters

Headline Unavailable

14 days ago·United Kingdom

Read Full Article

USA Today

Eli Lilly weight loss drug shows promise treating sleep apnea, long linked to obesity

The results, while unpublished, are the latest in a string of hopeful signs for weight loss drugs to treat a variety of conditions.

14 days ago·United States

Read Full Article

CNN

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday.

14 days ago·Atlanta, United States

Read Full Article

KRDO

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

By Jen Christensen, CNN (CNN) — Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea. Obstructive sleep apnea is a disorder that causes people to briefly sto…

13 days ago·Colorado Springs, United States

Read Full Article

KIFI

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

14 days ago·Idaho Falls, United States

Read Full Article

CNBC

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.

14 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources0

Leaning Left9Leaning Right0Center40Last Updated13 days agoBias Distribution

82% Center

Bias Distribution

82% of the sources are Center

82% Center

+35

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Weight-loss drug linked to sleep apnea reduction: Research

0 Articles

0 Articles

Headline Unavailable

Headline Unavailable

Eli Lilly weight loss drug shows promise treating sleep apnea, long linked to obesity

Eli Lilly weight loss drug shows promise treating sleep apnea, long linked to obesity

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics